Embedded on the page ‘We expand your network’
Three life science-professionals share their experience and insights from the Japanese life science-sector and the many untapped opportunities for Swedish companies.
Digital therapeutics, the costs of gene and cell therapies, and a challenging financing situation were some of the highlights at J.P. Morgan’s annual healthcare meeting in San Francisco in January.
The big number of attendees and parallel activities make JP Morgan Healthcare week an exceptional event, which is why SwedenBIO offers support to Swedish companies looking to head west for new business opportunities.
Welcome to our yearly winter gathering SwedenBIO Summit, which takes place at Grand Hôtel in Stockholm on the 6th of December 2022.
Nordic Life Science Days 2022 is set to break the record for attendance, as fundamentals remain strong in one of the world’s leading biotech ecosystems.
The Nordics gather with more than 100 companies in the Nordics Pavillion at BIO2022.
Att gå från ”Show stopper” till ”Game changer” i hanteringen av kompetensbehov.
As one of the actors in the Nordic consortium for life science, SwedenBIO has partnered up with BIO to offer our members a special discounted rate for the world’s biggest life science convention, BIO International Convention. The event takes place in San Diego, USA, on June 13-16, 2022.
Welcome back to a physical NLSDays – the largest Nordic partnering conference dedicated to the life science industry. Next year's event will take place in Malmö over two days, filled-to-the-brim with exciting content and phenomenal partnering possibilities. Register before November 1 to receive the early bird-discount!
In a recent mapping of the Swedish and Californian life science sectors, several common areas of strengths were identified, notably immuno-oncology, rare diseases/orphan drugs and cell and gene therapy. This has spurred a new link forming between these life science hot spots to secure that opportunities for innovative and brilliant minds to join forces in tackling health challenges are not lost.
How to create sustainable trading on the stock exchange
The life science sector is one of the strongest for listed small companies in Sweden. At the same time, the competition in the sector is fierce and it is necessary to work with the issues that affect share trading. A well-functioning share trading is important for creating growth in small and medium-sized companies.
Offer to you as an incubator company
Life for startup companies was not without challenges before the effects of the corona crisis hit, and the situation is now tough for many smaller companies. Now we want to contribute to building Sweden’s next generation of life science companies strong, for future export revenue and innovation power. Startup companies with up to four employees must be members of SwedenBIO for an annual fee of SEK 1,000.
Brännpunkt Life Science is an interview series in collaboration with DNB Sweden that focuses the magnifying glass on the intersection between innovation, capital and health. In the first part, we meet Adam Kostyal, European head of listing at Nasdaq, who looks at how the stock market year looked for the sector, talks about the impact of the pandemic and shares his predictions for the future.
